Andre Turenne is President & CEO of Voyager Therapeutics, Inc.. Currently has a direct ownership of 322,375 shares of VYGR, which is worth approximately $1.75 Million. The most recent transaction as insider was on Mar 19, 2021, when has been sold 80,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 322K
0% 3M change
0% 12M change
Total Value Held $1.75 Million

Andre Turenne Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2021
BUY
Grant, award, or other acquisition
-
80,000 Added 19.88%
322,375 Common Stock
Feb 16 2021
BUY
Grant, award, or other acquisition
-
94,000 Added 27.95%
242,375 Common Stock
Feb 11 2021
SELL
Open market or private sale
$60,226 $7.55 p/Share
7,977 Reduced 5.1%
148,375 Common Stock
Jan 12 2021
SELL
Open market or private sale
$90,019 $8.62 p/Share
10,443 Reduced 6.26%
156,352 Common Stock
AT

Andre Turenne

President & CEO
Cambridge, MA

Track Institutional and Insider Activities on VYGR

Follow Voyager Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

News

Receive news related to Voyager Therapeutics, Inc.

Track Activities on VYGR